Cargando…

Effect of phosphodiesterase‐4 inhibitor rolipram on colonic hypermotility in water avoidance stress rat model

BACKGROUND: Phosphodiesterase (PDE) inhibition has been reported to play a role in regulating gut motility, but the evidence is insufficient, and the mechanism remains unknown. The aim of this study was to investigate the possible role of phosphodiesterase‐4 (PDE4) inhibitor rolipram in water avoida...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, FangTing, Ren, HaiXia, Tan, Wei, Wang, Ying, Luo, HeSheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286810/ https://www.ncbi.nlm.nih.gov/pubmed/35037375 http://dx.doi.org/10.1111/nmo.14317

Ejemplares similares

Effect of Evodiamine on Rat Colonic Hypermotility Induced by Water Avoidance Stress and the Underlying Mechanism
por: Ren, HaiXia, et al.
Publicado: (2021)

The Effects of Short-Chain Fatty Acids on Rat Colonic Hypermotility Induced by Water Avoidance Stress
por: Yuan, FangTing, et al.
Publicado: (2020)

The effects of Saccharomyces boulardii on rat colonic hypermotility induced by repeated water avoidance stress and the potential mechanism
por: Liu, Jingwen, et al.
Publicado: (2022)

Plasma Hormones Facilitated the Hypermotility of the Colon in a Chronic Stress Rat Model
por: Liang, Chengbai, et al.
Publicado: (2012)

Actions of Hydrogen Sulfide and ATP-Sensitive Potassium Channels on Colonic Hypermotility in a Rat Model of Chronic Stress
por: Liu, Ying, et al.
Publicado: (2013)

Rolipram: Eotaxin and phosphodiesterase IV inhibitor versus bronchial hyper-reactivity response
por: Khan, Hamza Hassan, et al.
Publicado: (2015)

Phosphodiesterase Type 4 Inhibitor Rolipram Improves Survival of Spiral Ganglion Neurons In Vitro
por: Kranz, Katharina, et al.
Publicado: (2014)

Rolipram, a Phosphodiesterase 4 Inhibitor, Stimulates Inducible cAMP Early Repressor Expression in Osteoblasts
por: Cho, Eun Sook, et al.
Publicado: (2005)

Role of High-affinity Choline Transporter 1 in Colonic Hypermotility in a Rat Model of Irritable Bowel Syndrome
por: Lin, Meng-juan, et al.
Publicado: (2018)

Colonic Hypermotility in a Rat Model of Irritable Bowel Syndrome Is Associated with Upregulation of TMEM16A in Myenteric Plexus
por: Lin, Meng-juan, et al.
Publicado: (2018)

Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 (PDE4) inhibitor rolipram on behavior depend on cyclic AMP-response element binding protein (CREB)-mediated neurogenesis in the hippocampus
por: Li, Yun-Feng, et al.
Publicado: (2009)

Phosphodiesterase-4 inhibition with rolipram attenuates hepatocellular injury in hyperinflammation in vivo and in vitro without influencing inflammation and HO-1 expression
por: Wollborn, Jakob, et al.
Publicado: (2015)

Effect of rolipram, a phosphodiesterase enzyme type–4 inhibitor, on γ-amino butyric acid content of the frontal cortex in mice exposed to chronic mild stress
por: Shalaby, Amany Mohamed, et al.
Publicado: (2012)

Rolipram, a Selective Phosphodiesterase 4 Inhibitor, Ameliorates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain through Inhibition of Inflammatory Cytokines in the Dorsal Root Ganglion
por: Kim, Hee Kee, et al.
Publicado: (2017)

Phosphodiesterase-5 inhibitors for colon cancer chemoprevention
por: Islam, Bianca N., et al.
Publicado: (2018)

The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat
por: Rutten, K., et al.
Publicado: (2007)

Toxoplasma gondii-infected natural killer cells display a hypermotility phenotype in vivo
por: Ueno, Norikiyo, et al.
Publicado: (2015)

Serine 26 in the PomB Subunit of the Flagellar Motor Is Essential for Hypermotility of Vibrio cholerae
por: Halang, Petra, et al.
Publicado: (2015)

Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2a
por: Huang, Huili, et al.
Publicado: (2019)

Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
por: Rutten, K., et al.
Publicado: (2007)

Zaprinast and Rolipram Enhances Spatial and Emotional Memory in the Elevated Plus Maze and Passive Avoidance Tests and Diminishes Exploratory Activity in Naive Mice
por: Akar, Furuzan, et al.
Publicado: (2014)

Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis
por: Gobejishvili, Leila, et al.
Publicado: (2022)

Rolipram Improves Outcome in a Rat Model of Infant Sepsis-Induced Cardiorenal Syndrome
por: Sims, Clark R., et al.
Publicado: (2017)

The combination of rolipram and cilostamide improved the developmental competence of cloned porcine embryos
por: Tanga, Bereket Molla, et al.
Publicado: (2023)

An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
por: Pagano, Ester, et al.
Publicado: (2016)

Mutations Affecting HVO_1357 or HVO_2248 Cause Hypermotility in Haloferax volcanii, Suggesting Roles in Motility Regulation
por: Collins, Michiyah, et al.
Publicado: (2020)

Contribution of sewage to occurrence of phosphodiesterase-5 inhibitors in natural water
por: Hong, Youngmin, et al.
Publicado: (2021)

Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants
por: Tiwari, Amit K., et al.
Publicado: (2013)

Protective Effect of Administered Rolipram against Radiation-Induced Testicular Injury in Mice
por: Lee, Wan, et al.
Publicado: (2015)

The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
por: Dong, Xiao-Liu, et al.
Publicado: (2021)

Increased Capsule Thickness and Hypermotility Are Traits of Carbapenem-Resistant Acinetobacter baumannii ST3 Strains Causing Fulminant Infection
por: Rakovitsky, Nadya, et al.
Publicado: (2021)

A Non-Systemic Phosphodiesterase-5 Inhibitor Suppresses Colon Proliferation in Mice
por: Lee, Avelina, et al.
Publicado: (2023)

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy
por: Fessel, Jeffrey
Publicado: (2022)

Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer
por: Ammar, Lina, et al.
Publicado: (2023)

Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015)

Effect of phosphodiesterase inhibitors in the bladder
por: Chughtai, Bilal, et al.
Publicado: (2015)

Mast Cell Specific Receptor Mrgprb2 Regulating Experimental Colitis is Associated with the Microbiota-Gut-Brain Axis
por: Shao, Ming, et al.
Publicado: (2022)

Protective effects of rolipram on endotoxic cardiac dysfunction via inhibition of the inflammatory response in cardiac fibroblasts
por: Ji, Jingjing, et al.
Publicado: (2020)

The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain
por: Guo, Chi-Hua, et al.
Publicado: (2016)

PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase‐1 by a mechanism dependent on MAP kinase phosphatase‐1
por: Tuure, Lauri, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_smsjj4bglc0gssslsqhuj4c25r